Björn Windshügel

Prof. Dr. Björn Windshügel

Fraunhofer Institute for Molecular Biology and Applied Ecology IME, ScreeningPort, Hamburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Science of The Total Environment
Verified
Journal Article
Open access
OKOliver Keminer
Oliver Keminer
MTMatthias Teigeler
Matthias Teigeler
MKManfred Kohler
Manfred Kohler
AWAndrea Wenzel
Andrea Wenzel
JAJürgen Arning
Jürgen Arning
EEElke Eilebrecht
Elke Eilebrecht
Bisphenol A (BPA) is a high production volume chemical with a broad application spectrum. As an endocrine disrupting chemical, mainly by modulation of nuclear receptors (NRs), BPA has an adverse impact on organisms and is identified as a substance of very high concern under the European REACH regulation. Various BPA substitution candidates have been developed in recent years, however, information concerning the endocrine disrupting potential of these substances is still incomplete or missing. In this study, we intended to investigate the endocrine potential of BPA substitution candidates used in environmentally relevant applications such as thermal paper or epoxy resins. Based on an extensive literature and patent search, 33 environmentally relevant BPA substitution candidates were identified. In order to evaluate the endocrine potential of the BPA replacements, a screening cascade consisting of biochemical and cell-based assays was employed to investigate substance binding to the NRs estrogen receptor α and β, as well as androgen receptor, co-activator recruitment and NR-mediated reporter gene activation. In addition, a computational docking approach for retrospective prediction of receptor binding was carried out. Our results show that some BPA substitution candidates, for which so far no or only very few data were available, possess a substantial endocrine disrupting potential (TDP, BPZ), while several substances (BPS, D-8, DD70, DMP-OH, TBSA, D4, CBDO, ISO, VITC, DPA, and DOPO) did not reveal any NR binding.

20 December 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CMCarlos Moreno-Cinos
Carlos Moreno-Cinos
ESElisa Sassetti
Elisa Sassetti
ISIrene G. Salado
Irene G. Salado
GWGesa Witt
Gesa Witt
SBSiham Benramdane
Siham Benramdane
KAKoen Augustyns
Koen Augustyns

22 January 2018 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
Oliver BurkOliver Burk
Oliver Burk
MKMaria Kuzikov
Maria Kuzikov
TKThales Kronenberger
Thales Kronenberger
JJJudith Jeske
Judith Jeske
OKOliver Keminer
Oliver Keminer
Björn WindshügelBjörn Windshügel
Björn Windshügel

8 December 2020 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
LCLaura Chachulski
Laura Chachulski
Björn WindshügelBjörn Windshügel
Björn Windshügel

1 November 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
AGA. Gilardi
A. Gilardi
SBS.P. Bhamidimarri
S.P. Bhamidimarri
Mark BrönstrupMark Brönstrup
Mark Brönstrup
UBU. Bilitewski
U. Bilitewski
RMR.K.R. Marreddy
R.K.R. Marreddy
Björn WindshügelBjörn Windshügel
Björn Windshügel

31 January 2019 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
Björn WindshügelBjörn Windshügel
Björn Windshügel
The nuclear receptor Nurr1 (NR4A2) has been identified as a potential target for the treatment of Parkinson’s disease. In contrast to most other nuclear receptors, the X-ray crystal structure of the Nurr1 ligand-binding domain (LBD) lacks any ligand-binding pocket (LBP). However, NMR spectroscopy measurements have revealed that the known Nurr1 agonist docosahexaenoic acid (DHA) binds to a region within the LBD that corresponds to the classical NR ligand-binding pocket (LBP). In order to investigate the structural dynamics of the Nurr1 LBD and to study potential LBP formation, the conformational space of the receptor was sampled using a molecular dynamics (MD) simulation. Docking of DHA into 50,000 LBD structures extracted from the simulation revealed the existence of a transient LBP that is capable to fully harbor the compound. The location of the identified pocket overlaps with the ligand-binding site suggested by NMR experiments. Structural analysis of the protein-ligand complex showed that only modest structural rearrangements within the Nurr1 LBD are required for LBP formation. These findings may support structure-based drug discovery campaigns for the development of receptor-specific agonists.